Atrial fibrillation (AF) is considered a risk factor for isolated tricuspid valve regurgitation (TR) in the absence of other known etiologies. This study sought to identify the incidence of clinically significant isolated TR and its impact in patients with AF.

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
Sri Harsha Patlolla, MBBS, MS
Hartzell V. Schaff, MD

Date of Release: December 5, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: December 4, 2023